We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Big Pharma Challenges FDA's New Off-Label Rule

Law360, New York (February 9, 2017, 4:27 PM EST) -- Big Pharma is calling on the U.S. Food and Drug Administration to overhaul a newly finalized regulation giving the agency wide latitude to police off-label promotion, saying it contains abrupt and...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.